Back to Webinars

3rd Annual Research Round-Up

Tuesday, January 20, 2026
2:00am PST
1 hour

Join us!

Let’s look back at 2025 research with a fast, focused review of the most impactful genetics papers of the year and what they mean for real world clinical decision making. In this live, 60minute webinar, Ambry’s experts will break down key findings, highlight clinical implications across oncology and rare disease, and share practical guidance you can apply immediately.

During this engaging session, Ambry experts will present 10 of the most significant publications from 2025 in a fast-paced, journal club-style format.

You’ll learn:

  • Which 2025 publications matter most, from newly released guidelines to the implementation of genetics into primary care —and why they rise above the noise
  • How new evidence should influence testing strategies, reporting, and followup care
  • Emerging research topics to watch in 2026

*CEU credit is not available for this webinar.*

5bb4ef354990f
Carrie Horton
Clinical Strategy Manager – Clinical Research & Collaborations at Ambry Genetics
Ms. Horton received her M.S. in Genetic Counseling from Arcadia University and practiced clinically as a cancer genetic counselor in Memphis, TN prior to joining Ambry Genetics 6 years ago. As a reporting genetic counselor at Ambry, she performed variant assessment, generated reports for oncology tests, and curated clinical literature for report content. In her […]

Ms. Horton received her M.S. in Genetic Counseling from Arcadia University and practiced clinically as a cancer genetic counselor in Memphis, TN prior to joining Ambry Genetics 9 years ago. During her time at Ambry, she first took on the role of reporting genetic counselor, performing variant assessment and generating test reports. She has also acted as a Senior Clinical Research Specialist, conducting studies that focus on the translational application of Ambry’s research to solve clinical dilemmas in the oncology setting. In her current role as Medical Science Liaison for Clinical Research, she coordinates multi-disciplinary and multi-institutional initiatives to improve engagement, promotion, and dissemination of key research findings. Ms. Horton’s research interests include improving the clinical utility of and increasing access to genetic testing.

6942e26eb964e993439032
Holly Laduca
Clinical Strategy Manager at Ambry Genetics
     

Holly LaDuca is a Clinical Strategy Manager at Ambry Genetics, focusing on hereditary cancer. After beginning her career as a community-based cancer genetic counselor, she has spent over 10 years applying her genetic counseling skillset in laboratory and digital health settings. During this time, she has collaborated on 60+ publications. Ms. LaDuca is concurrently pursuing a PhD in Translational Health Science to help bridge gaps between research and practice and to integrate implementation science principles into clinical genetics and precision public health. She also enjoys engaging with genetic counseling students, especially to support thesis projects.